Targeting internal proteins instead of spike proteins may be a promising strategy for monoclonal antibody therapy to combat SARS-CoV-2, the virus that causes COVID-19.
Menu
Browsing: Allergy & Immunology
In the newly formed Center for Human Immunobiology, teams of interdisciplinary scientists and clinicians will work together to understand the immune system at the molecular level and translate new discoveries into cures for immune-regulated diseases.
Northwestern scientists have developed a new tool to harness immune cells from tumors to fight cancer rapidly and effectively.
Feinberg scientists including the lab of William Muller, MD, PhD, are investigating how regulating inflammation can be a pathway to treating a range of diseases.
A new Northwestern study has discovered a technique to help make immunomodulation more effective, potentially improving treatment for type 1 diabetes.
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas — the most common and malignant of primary brain tumors — might benefit from immunotherapy.
A new Northwestern Medicine study has uncovered herpes’ sneaky strategy for infecting the nervous system, opening a path to long-needed vaccine development for the virus.
Coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses, paving the way for future universal coronavirus vaccines.
Northwestern Medicine scientists have developed an antibody that they believe can be used to treat muscular dystrophy, reducing muscle scarring in an animal model of the disease.
Stephanie Eisenbarth, MD, PhD, of Yale University, has been named chief of Feinberg’s Division of Allergy and Immunology in the Department of Medicine, and director of the newly formed Center for Human Immunobiology.